9 March 2023 · Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.
1 March 2022 · National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
20 October 2021 · Local decision makers should choose between the options for giving fidaxomicin orally. Licensing status and other factors affect decision making.